Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: Predictors of Response to Iron and Erythropoietin Stimulating Agents
NCT03658876Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jun 2015
- Primary completion
- Dec 2016
- Modality
- Erythropoietins, Colony Stimulating Factors, Small Molecules
01
Overview
A Phase 4 trial of iron sucrose, epoetin beta in anemia, chronic kidney disease (CKD), sponsored by Imperial College London. Started Jun 2015; status: completed.
02
Drugs
iron sucroseepoetin beta
03
Conditions
anemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03658876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658876.